RGNX

REGENXBIO Stock Price

44.99
1.71 (3.95%)
44.99
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
REGENXBIO Inc RGNX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.71 3.95% 44.99 17:15:00
Open Price Low Price High Price Close Price Prev Close
43.17 42.22 45.10 44.99 43.28
Bid Price Ask Price Spread News
42.10 46.50 4.40 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,832 312,542 $ 43.94 $ 13,733,374 640,643 20.03 - 54.97
Last Trade Time Type Quantity Stock Price Currency
16:43:42 priorref 297 $ 44.99 USD

REGENXBIO Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.90B 42.31M 28.51M $ 35.23M $ -17.20M -2.59 -17.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

REGENXBIO News

Date Time Source News Article
1/12/202116:05PR Newswire (US)REGENXBIO Announces Closing Of Public Offering Of Common..
1/11/202116:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
1/11/202107:05PR Newswire (US)REGENXBIO to Present at the 39th Annual J.P. Morgan..
1/08/202116:26Edgar (US Regulatory)Current Report Filing (8-k)
1/08/202107:05PR Newswire (US)REGENXBIO Announces Pricing Of Public Offering Of Common..
1/06/202116:35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
1/06/202116:01PR Newswire (US)REGENXBIO Announces Proposed Public Offering Of Common Stock
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RGNX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week48.3449.6341.5044.38657,437-3.35-6.93%
1 Month49.9450.2641.5047.02696,485-4.95-9.91%
3 Months28.9750.2627.14541.95496,55916.0255.3%
6 Months36.7950.2625.92536.28407,1698.2022.29%
1 Year42.9054.9720.0336.92420,4692.094.87%
3 Years29.1585.1020.0346.26490,86015.8454.34%
5 Years13.4185.107.070140.38385,98131.58235.5%

REGENXBIO Description

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).
Your Recent History
NASDAQ
RGNX
REGENXBIO
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210125 23:59:51